Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany

Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01880-16. doi: 10.1128/AAC.01880-16. Print 2017 Mar.

Abstract

The metallo-beta-lactamase GIM-1 has been found in various bacterial host species nearly exclusively in western Germany. However, not much is known about the epidemiology of GIM-1-positive Serratia marcescens Here we report on a surprisingly protracted regional dissemination. In-hospital transmission was investigated by using conventional epidemiological tools to identify spatiotemporal links. Strain typing was performed using pulsed-field gel electrophoresis (PFGE) and whole-genome sequencing (WGS). Bayesian phylogeny was used to infer the time axis of the observed occurrence. Thirteen S. marcescens strains from 10 patients from 6 different German hospitals were investigated. Suspected in-hospital transmissions were confirmed by molecular typing at a higher resolution by WGS than by PFGE. A detailed sequence analysis demonstrated the spread of one predominant strain variant but also provided evidence for transfer of the blaGIM-1 gene cassette between different strains. A Bayesian phylogenetic analysis showed that the most recent common ancestor of the identified clonal cluster could be dated back to April 1993 (95% highest posterior density interval, January 1973 to March 2003) and that this strain might have already harbored the blaGIM-1 at that time and, therewith, years before the first detection of this resistance gene in clinical specimens. This study shows a long-standing clonal and plasmid-mediated expansion of GIM-1-producing S. marcescens that might have gone unnoticed in the absence of a standardized and effective molecular screening for carbapenemases. The systematic and early detection of resistance is thus highly advisable, especially for the prevention of potentially long-term dissemination that may progress beyond control.

Keywords: Serratia; beta-lactamases; infection control; molecular epidemiology.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Typing Techniques
  • Bayes Theorem
  • Clone Cells
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Cross Infection / transmission*
  • Electrophoresis, Gel, Pulsed-Field
  • Gene Expression
  • Genome, Bacterial*
  • Genotype
  • Germany
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Epidemiology
  • Phylogeny*
  • Plasmids / chemistry
  • Plasmids / metabolism
  • Serratia Infections / drug therapy
  • Serratia Infections / epidemiology
  • Serratia Infections / microbiology
  • Serratia Infections / transmission*
  • Serratia marcescens / classification
  • Serratia marcescens / drug effects
  • Serratia marcescens / genetics*
  • Serratia marcescens / growth & development
  • beta-Lactam Resistance / genetics*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases